Home > News > SurgRx Secures $5 Million in Second-Round Venture Capital Financing
January 16th, 2004
SurgRx Secures $5 Million in Second-Round Venture Capital Financing
Abstract:
SurgRx, a developer of proprietary nanotechnology designed to control the delivery of electro surgical energy in vessel sealing instruments used to achieve hemostasis during surgery, announced today that it has received $5 million in second-round venture financing led by California Technology Ventures (CTV). This is the first investment in SurgRx from CTV, a leading venture capital firm specializing in early-stage companies in the information technology and life sciences marketplaces.
Source:
Businesswire
Bookmark:
Investments/IPO's/Splits
Dr. Ben J. Lipps designated as Chairman of the Management Board and Chief Executive Officer of Nanostart-holding MagForce AG June 17th, 2013
Harris & Harris Group Notes Carl Zeiss' Planned Acquisition of Xradia June 13th, 2013
Long Island Capital Alliance Announces Participants for Biotech Technology Transfer Capital Forum: Event to Be Held on June 14 in Collaboration With Cold Spring Harbor Laboratory June 8th, 2013
Iran to Hold Int'l Forum on Nanotechnology Economy (IFNE2013) May 30th, 2013
Profiles
Russia’s Nano-enabled Products Market to Witness Massive Growth February 8th, 2011
Adept Technology Announces Orders for Over $600K from Chinese Partner January 18th, 2011
Nanostart-held ItN Nanovation Receives Major Follow-on Order in Saudi Arabia November 29th, 2010
Homegrown Companies Developing Batteries for Clean Energy Storage November 2nd, 2010